Walsh Jeffrey T. 4
4 · bluebird bio, Inc. · Filed Jun 20, 2019
Insider Transaction Report
Form 4
Walsh Jeffrey T.
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2019-06-18$24.47/sh+100$2,447→ 41,021 total - Exercise/Conversion
Stock Option (right to buy)
2019-06-18−100→ 10,021 totalExercise: $24.47Exp: 2024-03-03→ Common Stock (100 underlying) - Sale
Common Stock
2019-06-18$126.12/sh−100$12,612→ 40,921 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 2, 2018.
- [F2]This option vested over a four-year period, at a rate of twenty-five percent (25%) on January 1, 2015 and in 36 equal monthly installments thereafter.